respiratory disease
At the ADLM annual meeting, firms said they see game-changing opportunities for platforms that provide the right combination of clinical utility and convenience.
The Berlin, Germany-based firm said it plans to expand its test menu to take on many more infectious diseases with its portable molecular instrument.
Abbott, Hologic, Becton Dickinson Secure FDA Clearances in May
The clearances granted in May by the US Food and Drug Administration include a laboratory instrument system, respiratory disease panels, and MRSA detection software.
AmplifiDx Gets $1.4M NIH RADx Grant for Point-of-Care Molecular Testing Instrument
The Massachusetts-based firm plans to use the funding toward development of its nucleic acid amplification test platform and multiplex respiratory test.
Blu Biotech, U of Michigan to Develop, Seek Approval for Breath-Based Test for Sepsis, ARDS
The firm will use biomarkers licensed from the University of Michigan to develop and commercialize an assay for identifying disease and monitoring treatments.